A catalytic composition for preparing a polyethylene terephthalate (PET) resin is provided. The catalytic composition comprises a polycondensation catalyst and cesium tungsten oxide (Cs.sub.xWO.sub.3-yCl.sub.y), and 0<x≦1 and 0≦y≦0.5. A PET resin prepared by the catalytic composition above is also provided. The PET resin comprises 2-80 ppm of cesium tungsten oxide. This catalytic composition can solve the problems of slow solid-state polymerization rate of the PET preparation and thus the long preparation time, as well as yellowing. Moreover, the PET resin can absorb infrared radiation.

Abstract: A container body which comprises a base and a side wall extending from the base, wherein said container body includes a polyester and a polymer YY. wherein said polymer YY is selected from the group comprising cyclic block copolymers (CBC) and cyclic olefin polymers (COP).

The present invention relates to a blend containing at least two different polyolefins which is characterized in that it contains as a further constituent an amorphous poly-alpha-olefin which is based on the monomers ethene, propene and 1-butene and has a viscosity at 190° C. of 200 mPa*s to 200,000 mPa*s, wherein it contains polyethylene and polypropylene as at least two different polyolefins and wherein the polyethylene has a melt flow index [MFI 2.16 kg@190° C.] determined according to the method ISO 1133 reported in the description of less than 10 g/10 min, preferably of 0.01 to 2 g/10 min, and the polypropylene has a melt flow index [MFI 2.16 kg@230° C.] determined according to the method reported in the description of less than 50 g/10 min, preferably of 0.01 to 25 g/10 min, to a process for producing such blends and to the use thereof.

A container body comprises a base, a side wall extending from the base and a neck portion arranged to engage a closure for the container body, wherein: (i) said container body includes a cyclic olefin copolymer (COC) and polyester; or (ii) said container body includes a polymethylpentene (PMP) and polyester; wherein, in both cases (i) and (ii), the side wall of the container body has an L* of at least 90 and the neck portion has an L* of at least 84.

The disclosure relates to light barrier compositions, methods of making the compositions, articles prepared from the compositions, and methods of making the articles. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

There is provided a co-injection molded multilayer structure comprising a barrier layer and outer layers laminated to contact with the barrier layer on its both sides, wherein the barrier layer is made of a resin composition (X) comprising an ethylene-vinyl alcohol copolymer (A) and an alkali metal salt (B) of a higher fatty acid, having a melting point of 250° C. or lower; the ethylene-vinyl alcohol copolymer (A) has an ethylene unit content of 20 to 60 mol % and a saponification degree of 90% or more, and a content of the alkali metal salt (B) in the barrier layer is 50 to 1500 ppm in terms of metal atoms; and the outer layers are made of a resin composition (Y) comprising an unmodified high-density polyethylene (F) and a maleic anhydride-modified polyethylene (G), and a maleic anhydride modification rate relative to the whole resin composition (Y) is 0.005 to 0.1 wt %. This co-injection molded multilayer structure has excellent adhesiveness, so that its oxygen barrier performance can be maintained even after being subjected to an impact due to falling or the like.

A biobased polymer composition for pharmaceutical articles includes a low density polyethylene, in which at least a portion of ethylene is obtained from a renewable source of carbon. The biobased polymer composition exhibits an Emission Factor ranging from −3.5 to 0 kg CO2.sub.e/kg of the biobased polymer composition, and is biocompatible for use in pharmaceutical packaging. A pharmaceutical article includes the biobased polymer composition and has a volume ranging from 0.04 ml to 10000 ml. A method for forming a pharmaceutical article includes extruding the biobased polymer composition at a temperature ranging from 100 to 250° C. and at a screw speed ranging from 20 to 100 rpm. A method for producing a biobased polymer composition includes polymerizing ethylene at least partially obtained from a renewable source of carbon to form a low density polyethylene.

A degradable containment includes an outer structural layer constructed of a pulp material, a central carrier layer constructed of a biopolymer, and an interior nanomaterial layer constructed of a nanomaterial.

The invention relates to a composition comprising: (A) a propylene-based polymer which is a propylene homopolymer or a propylene copolymer consisting of at least 90 wt % of propylene monomer units and at most 10 wt % of ethylene monomer units and/or an α-olefin monomer units having 4 to 10 carbon atoms, (B) an elastomer of ethylene and an α-olefin comonomer having 4 to 10 carbon atoms, wherein the elastomer has a density of 0.850 to 0.865 g/cm 3 and a melt flow index of 0.1 to 20 dg/min measured in accordance with ASTM D1238 using a 2.16 kg weight and at a temperature of 190° C. and (C) a block copolymer comprising a terminal block comprising styrene or alpha-methylstyrene.

A preform is made by mixing cyclic olefin copolymer (COC) and light shielding pigment(s) with PET. The preform is stretch-blow moulded to produce a bottle which may be white and opaque. Light may be restricted from entering the bottle to thereby restrict degradation of the bottle contents from certain wavelengths of visible light.